Notably, treatment of HNSCC patient-derived xenograft (PDX) model which displays high level of nuclear NICD1 and elevated DCLK1 expression with NOTCH inhibitor, resulted in a similar effect (Supplementary Figure 2B). This evidence concerns the gene DCLK1 and head and neck squamous cell carcinoma.